Methylphenidate Patch
Product Images NDC 0378-8260

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Methylphenidate (NDC 0378-8260). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Four Layers Of Patch And Cross-section Of The Patch (91799397 24d7 445f 8b23 56cc91ee4675 01)

A labeled cross-sectional illustration of a methylphenidate transdermal patch showing four layers: (1) Outside Backing, (2) Solid Matrix Drug Reservoir, (3) Adhesive Formulation, and (4) Protective Liner (noted as removed prior to application). The drawing is not to scale.*

FDA Label Image

Figure A (Image 01)

An instructional illustration showing the application of a transdermal patch labeled Methylphenidate. The image depicts a hand placing or adjusting the patch on the skin of the upper thigh area, demonstrating correct patch placement on the body.*

FDA Label Image

Figure B (Image 02)

An instructional diagram showing how to apply a transdermal patch. The image depicts a person using their hands to place the patch onto the skin on their upper arm or shoulder area. The patch is rectangular, and the illustration emphasizes proper handling and placement.*

FDA Label Image

Figure C And Figure D (Image 03)

An instructional diagram showing a Methylphenidate transdermal patch. It highlights the patch components including the protective liner and adhesive layers containing the medicine on the underside, and the outside backing. The patch is labeled with the active ingredient name "Methylphenidate" on the outside backing.*

FDA Label Image

Figure E (Image 04)

Illustration showing hands holding a Methylphenidate transdermal patch and its protective backing being peeled off, demonstrating how to prepare the patch for application.*

FDA Label Image

Figure F (Image 05)

An instructional illustration showing application of the Methylphenidate transdermal patch. It depicts hands placing the patch on skin, demonstrating proper patch placement technique.*

FDA Label Image

Figure G (Image 06)

An instructional diagram showing a hand applying a Methylphenidate transdermal patch to the upper arm or shoulder area, demonstrating proper patch placement for transdermal drug delivery.*

FDA Label Image

Figure H (Image 07)

An instructional illustration depicting the application of a Methylphenidate transdermal patch on the lower back or flank area, showing a person placing the patch onto the skin with the assistance of a hand.*

FDA Label Image

Methylphenidate Structural Formula (Image 08)

Chemical structure of methylphenidate showing the molecular arrangement including a phenyl ring, a piperidine ring with a nitrogen atom, and an ester functional group with a methoxy component.*

FDA Label Image

Methylphenidate Transdermal System 1.1 mg/hr Carton Label (Image 09)

Methylphenidate Transdermal System 1.1 mg/hr patch packaging label by Mylan Pharmaceuticals Inc. Delivers 10 mg over 9 hours, contains 30 systems per package. Includes directions for use, disposal method, and application site tracking table. NDC 0378-8260-93. Label highlights transdermal use only and importance of proper disposal and keeping out of reach of children.*

FDA Label Image

Methylphenidate Transdermal System 1.6 mg/hr Carton Label (Image 10)

Packaging label for Methylphenidate Transdermal System 1.6 mg/hr patch by Mylan Pharmaceuticals Inc. The label states the patch delivers 15 mg over 9 hours and contains 30 transdermal systems. It includes dosage and disposal instructions along with a chart to log application details. The label features the NDC number 0378-8261-93 and emphasizes transdermal use only.*

FDA Label Image

Methylphenidate Transdermal System 2.2 mg/hr Carton Label (Image 11)

Methylphenidate Transdermal System 2.2 mg/hr patch packaging label from Mylan Pharmaceuticals Inc. The label states the product delivers 20 mg over 9 hours, contains 30 systems, and includes instructions for use and disposal. The design features green and black text on a white background with blue accents and the Mylan logo.*

FDA Label Image

Figure 1 (Image 12)

A pharmacokinetic curve chart showing d-Methylphenidate concentration (ng/mL) over time (hours) following application of Methylphenidate transdermal system. The graph plots concentration on the vertical axis against time post-application on the horizontal axis, illustrating the drug's absorption and elimination phases over a 30-hour period.*

FDA Label Image

Methylphenidate Transdermal System 3.3 mg/hr Carton Label (Image 13)

Packaging label for Methylphenidate Transdermal System 3.3 mg/hr patch by Mylan Pharmaceuticals Inc. The label includes dosing and disposal instructions, an application log for record keeping, and states that the package contains 30 transdermal systems. The patch delivers 30 mg over 9 hours at a rate of 3.3 mg/hr and is for transdermal use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.